Medistim ASA

OB:MEDI Stock Report

Market Cap: NOK 3.9b

Medistim Management

Management criteria checks 3/4

Medistim's CEO is Kari Krogstad, appointed in Sep 2009, has a tenure of 15.67 years. total yearly compensation is NOK5.40M, comprised of 61.9% salary and 38.1% bonuses, including company stock and options. directly owns 0.26% of the company’s shares, worth NOK10.03M. The average tenure of the management team and the board of directors is 6.1 years and 1.7 years respectively.

Key information

Kari Krogstad

Chief executive officer

NOK 5.4m

Total compensation

CEO salary percentage61.94%
CEO tenure15.7yrs
CEO ownership0.3%
Management average tenure6.1yrs
Board average tenure1.7yrs

Recent management updates

We Think Some Shareholders May Hesitate To Increase Medistim ASA's (OB:MEDI) CEO Compensation

May 02
We Think Some Shareholders May Hesitate To Increase Medistim ASA's (OB:MEDI) CEO Compensation

Recent updates

Medistim ASA (OB:MEDI) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

May 13
Medistim ASA (OB:MEDI) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

We Think Some Shareholders May Hesitate To Increase Medistim ASA's (OB:MEDI) CEO Compensation

May 02
We Think Some Shareholders May Hesitate To Increase Medistim ASA's (OB:MEDI) CEO Compensation

There May Be Reason For Hope In Medistim's (OB:MEDI) Disappointing Earnings

Mar 07
There May Be Reason For Hope In Medistim's (OB:MEDI) Disappointing Earnings
author-image

Direct Sales In China, Canada, And Sweden Will Improve Market Control

Expansion into direct markets in China, Canada, and Sweden aims for higher growth through better control and margins than distributor sales.

Medistim ASA's (OB:MEDI) Shares May Have Run Too Fast Too Soon

Dec 13
Medistim ASA's (OB:MEDI) Shares May Have Run Too Fast Too Soon

Medistim ASA Just Missed Earnings - But Analysts Have Updated Their Models

Oct 28
Medistim ASA Just Missed Earnings - But Analysts Have Updated Their Models

Medistim ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 19
Medistim ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Medistim ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 04
Medistim ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

One Medistim ASA (OB:MEDI) Analyst Has Been Cutting Their Forecasts

Nov 10
One Medistim ASA (OB:MEDI) Analyst Has Been Cutting Their Forecasts

What Does Medistim ASA's (OB:MEDI) Share Price Indicate?

Dec 14
What Does Medistim ASA's (OB:MEDI) Share Price Indicate?

Should You Be Adding Medistim (OB:MEDI) To Your Watchlist Today?

Sep 06
Should You Be Adding Medistim (OB:MEDI) To Your Watchlist Today?

A Look At The Intrinsic Value Of Medistim ASA (OB:MEDI)

Jun 14
A Look At The Intrinsic Value Of Medistim ASA (OB:MEDI)

Medistim (OB:MEDI) Is Increasing Its Dividend To kr3.75

Apr 21
Medistim (OB:MEDI) Is Increasing Its Dividend To kr3.75

Medistim (OB:MEDI) Is Paying Out A Larger Dividend Than Last Year

Mar 31
Medistim (OB:MEDI) Is Paying Out A Larger Dividend Than Last Year

Statutory Profit Doesn't Reflect How Good Medistim's (OB:MEDI) Earnings Are

Mar 05
Statutory Profit Doesn't Reflect How Good Medistim's (OB:MEDI) Earnings Are

Medistim's (OB:MEDI) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 01
Medistim's (OB:MEDI) Shareholders Will Receive A Bigger Dividend Than Last Year

Medistim (OB:MEDI) Is Reinvesting To Multiply In Value

Jan 11
Medistim (OB:MEDI) Is Reinvesting To Multiply In Value

Medistim (OB:MEDI) Might Become A Compounding Machine

Sep 29
Medistim (OB:MEDI) Might Become A Compounding Machine

Here's Why I Think Medistim (OB:MEDI) Might Deserve Your Attention Today

Sep 07
Here's Why I Think Medistim (OB:MEDI) Might Deserve Your Attention Today

Here's What Medistim's (OB:MEDI) Strong Returns On Capital Mean

May 17
Here's What Medistim's (OB:MEDI) Strong Returns On Capital Mean

Is Medistim ASA's(OB:MEDI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Mar 19
Is Medistim ASA's(OB:MEDI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Medistim ASA (OB:MEDI) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 02
Medistim ASA (OB:MEDI) Just Reported And Analysts Have Been Lifting Their Price Targets

CEO Compensation Analysis

How has Kari Krogstad's remuneration changed compared to Medistim's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

NOK 123m

Dec 31 2024NOK 5mNOK 3m

NOK 104m

Sep 30 2024n/an/a

NOK 102m

Jun 30 2024n/an/a

NOK 104m

Mar 31 2024n/an/a

NOK 103m

Dec 31 2023NOK 7mNOK 3m

NOK 104m

Sep 30 2023n/an/a

NOK 117m

Jun 30 2023n/an/a

NOK 116m

Mar 31 2023n/an/a

NOK 116m

Dec 31 2022NOK 9mNOK 3m

NOK 114m

Sep 30 2022n/an/a

NOK 98m

Jun 30 2022n/an/a

NOK 92m

Mar 31 2022n/an/a

NOK 93m

Dec 31 2021NOK 6mNOK 3m

NOK 91m

Sep 30 2021n/an/a

NOK 88m

Jun 30 2021n/an/a

NOK 84m

Mar 31 2021n/an/a

NOK 70m

Dec 31 2020NOK 6mNOK 3m

NOK 69m

Sep 30 2020n/an/a

NOK 71m

Jun 30 2020n/an/a

NOK 74m

Mar 31 2020n/an/a

NOK 75m

Dec 31 2019NOK 4mNOK 3m

NOK 70m

Sep 30 2019n/an/a

NOK 79m

Jun 30 2019n/an/a

NOK 73m

Mar 31 2019n/an/a

NOK 64m

Dec 31 2018NOK 4mNOK 2m

NOK 57m

Compensation vs Market: Kari's total compensation ($USD523.38K) is about average for companies of similar size in the Norwegian market ($USD558.03K).

Compensation vs Earnings: Kari's compensation has been consistent with company performance over the past year.

CEO

Kari Krogstad (60 yo)

15.7yrs
Tenure
NOK 5,395,092
Compensation

Ms. Kari Eian Krogstad serves as Independent Director at Vistin Pharma ASA since June 24, a2020. She has been the Chief Executive Officer of Medistim ASA since September 1, 2009 and serves as its President...

Leadership Team

NamePositionTenureCompensationOwnership
Kari Krogstad
CEO & President15.7yrsNOK 5.40m0.26%
NOK 10.0m
Thomas Jakobsen
Chief Financial Officerno dataNOK 2.26m0.17%
NOK 6.5m
Helge Borslid
Vice President of Operationsno dataNOK 1.70mno data
Hæge Johanne Wetterhus
Vice President of Marketing14.8yrsNOK 1.84m0.0087%
NOK 338.9k
Hakon Grothe
Chief Innovation Officer6.1yrsNOK 1.85m0.043%
NOK 1.7m
Ole Eiksund
Chief Business Development Officer3.1yrsNOK 1.77m0.032%
NOK 1.3m
Roger Morberg
Vice President of Sales - APACno dataNOK 2.08m0.089%
NOK 3.5m
Stephanie Stenhagen
Vice President of Sales EMEAno dataNOK 1.71m0.015%
NOK 593.0k
Mike Karim
Chief Commercial Officerless than a yearno datano data
Ole Robsrud
Managing Director of Medistim Norge ASno dataNOK 1.83mno data
6.1yrs
Average Tenure
60yo
Average Age

Experienced Management: MEDI's management team is seasoned and experienced (6.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Oyvin Broymer
Chairman25.3yrsNOK 520.00kno data
Anna Ahlberg
Independent Director2.1yrsNOK 325.00k0.0022%
NOK 85.1k
Tove Raanes
Independent Director11.3yrsNOK 340.00k0.011%
NOK 424.0k
Peder Strand
Director1.3yrsNOK 305.00kno data
Gry Dahle
Independent Director1.3yrsNOK 290.00kno data
Rune Halvorsen
Directorno datano datano data
1.7yrs
Average Tenure
50.5yo
Average Age

Experienced Board: MEDI's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 07:26
End of Day Share Price 2025/05/19 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medistim ASA is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Magnus GranerødBeringer Finance AB
null nullDanske Bank
Geir HolomDNB Markets